drugset / Trial / NCT02706054

Treatment of Recent Onset Low Back Pain With Periradicular Injections of Meloxicam

NCT02706054

Phase 3 Completed 80 enrolled Rizzoli Orthopaedic Institute
RandomizedCrossoverQuadruple-blindTreatment

Summary

This randomized, double-blind, placebo control, cross-over study tested the hypothesis that periradicular injections of Meloxicam would reduce recent onset low back pain and improve physical activity compared to saline injection at 3 months follow-up evaluation

Timeline

Start
2012-05
Primary completion
2014-07
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule Intramuscular

Indications

No indication recorded.